Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Berne Stock Exchange  >  Galenica AG    GALN   CH0015536466

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Galenica AG
Develops and markets pharmaceutical products and provides logistical & database services

Galenica AG engages in the manufacturing, development and sale of pharmaceutical products.

It operates through the following segments: Vifor Pharma, Logistics, Retail, and HealthCare Information.

The Vifor Pharma segment operates a fully integrated, international speciality pharmaceutical company that researches, develops and produces its own pharmaceutical products, and markets and distributes them worldwide.

The Logistics segment provides product storage and distribution services to pharmaceutical and healthcare companies.

The Retail segment runs a chain of pharmacies under Amavita and Sun Store brand.

The HealthCare Information segment offers solutions for the networked healthcare market.

The company was founded in 1927 and is headquartered in Bern, Switzerland.
Managers
NameAgeSinceTitle
Etienne Jornod631981Executive Chairman
Jörg Kneubühler, PhD562002Chief Financial Officer & Controller
Daniela Bosshardt-Hengartner442008Non-Executive Director
Michel Burnier, MD632010Non-Executive Director
Hans Peter Frick, LLD702010Non-Executive Director
Stefano Pessina742000Non-Executive Director
Mathias Ernst Schneider642004Deputy Chairman
Fritz Hirsbrunner671977Executive Director
Sylvie Louise Grégoire, PhD532013Non-Executive Director
Marc M. P. de Garidel, MBA582015Director
Shareholders
NameEquities%
AB Acquisitions Holdings Ltd. 1,656,172 25.5%
Patinex AG 1,126,831 17.3%
Alecta Pension Insurance Mutual 210,000 3.23%
OppenheimerFunds, Inc. 170,429 2.62%
Norges Bank Investment Management 117,205 1.80%
The Vanguard Group, Inc. 101,767 1.57%
Remo Stoffel 70,000 1.08%
Credit Suisse AG 65,954 1.01%
Oddo Meriten Asset Management SA 48,900 0.75%
UBS AG (Investment Management) 46,971 0.72%
Holdings
NameEquities%Valuation
Galenica AG (GALN) 22,3980.34%35,601,567 USD
Sector
Consumer Non-Cyclicals
Food & Drug Retailing
 Food & Drug Retailing
  Drug Retailers
   Drug Retailers - NEC
Advertisement
Sector Drug Retailers
Growth (Revenue) Profitability
CVS HEALTH CORP
WALGREENS BOOTS A..
EXPRESS SCRIPTS H..
MCKESSON CORPORAT..
CARDINAL HEALTH I..
AMERISOURCEBERGEN..
GALENICA AG
CELESIO AG
-
JOINTOWN PHARMACE..
MEDIPAL HOLDINGS ..
LIAONING CHENG DA..
SUZUKEN CO., LTD.
CHINA NATIONAL AC..
WELCIA HOLDINGS C..
JEAN COUTU GROUP ..
MATSUMOTOKIYOSHI ..
PRESTIGE BRANDS H..
SHANDONG REALCAN ..
CHINA NATIONAL ME..
TOHO HOLDINGS CO ..
Sector Drug Retailers
Galenica AG : Connections
VenCap 6 Ltd.
European Society of Hypertension
Speedel Pharma AG
Neue Zürcher Zeitung AG
Centre Hospitalier Universitaire Vaudois
Swiss Society of Hypertension
The International Institute for Conflict Prevention & Resolut
de L’ecole des Hautes Etudes Appliquées du Droit
European Research Council
Walgreen Co.
ESSEC Business School
Swiss Society of Nephrology
Alliance Boots GmbH
Ipsen Pharma SAS
Shire Orphan Therapies GmbH
European Federation of Pharmaceutical Industries & Assns
Alliance Boots Holdings Ltd.
Suraypharm SAS
Pharnext SAS
Alliance Boots Ltd.
Société Des Membres De La Légion D'Honneur
IVF HARTMANN AG
ESCP Europe Campus Paris
Company contact information
8 Untermattweg
CH-3027 Bern, Bern
Switzerland

Phone : +41 58 852 81 11
Fax : +41 58 852 81 12
Internet : http://www.galenica.com
Markets and indexes
- SIX Swiss Exchange
- Main Standard
Stock Exchange Codes
- ISIN Code :  CH0015536466
- Bloomberg Code :  GALN:SW
- Reuters Code :  GALN.S
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem